Increased numbers of MRGPRX2+ MCs were seen in lesional skin of patients with MC-driven disorders, such as chronic spontaneous urticaria (11), chronic prurigo (12) and cutaneous mastocytosis (10). Here, MRGPRX2 is linked to cutaneous mastocytosis.